14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC, Meza-Montenegro MM, Peña R, Peña EM, Salazar-Martínez E, Correa P, Martínez ME, Valdivieso M, Goodman GE, Crowley JJ, Baker LH
Lancet. 2011 378 (9790): 507-14

PMID: 21777974 · PMCID: PMC3313469 · DOI:10.1016/S0140-6736(11)60825-8

MeSH Terms (22)

2-Pyridinylmethylsulfinylbenzimidazoles Adult Aged Amoxicillin Anti-Bacterial Agents Breath Tests Clarithromycin Drug Administration Schedule Drug Therapy, Combination Female Helicobacter Infections Helicobacter pylori Humans Lansoprazole Latin America Male Metronidazole Middle Aged Proton Pump Inhibitors Time Factors Treatment Outcome Urea

Connections (1)

This publication is referenced by other Labnodes entities:

Links